These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34051033)

  • 1. Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    O'Neill BP; Grines C; Moses JW; Ohman EM; Lansky A; Popma J; Kapur NK; Schreiber T; Mannino S; O'Neill WW; Medjamia AM; Mahmud E
    Catheter Cardiovasc Interv; 2021 Oct; 98(4):E501-E512. PubMed ID: 34051033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock.
    Al-Khadra Y; Alraies MC; Darmoch F; Pacha HM; Soud M; Kaki A; Rab T; Grines CL; Meraj P; Alaswad K; Kwok CS; Mamas M; Kapadia S
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):503-512. PubMed ID: 31254325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
    Hirai T; Grantham JA; Kandzari DE; Ballard W; Brown WM; Allen KB; Kirtane AJ; Argenziano M; Yeh RW; Khabbaz K; Lombardi W; Lasala J; Kachroo P; Karmpaliotis D; Gosch KL; Salisbury AC;
    Catheter Cardiovasc Interv; 2023 Nov; 102(5):814-822. PubMed ID: 37676058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes in patients undergoing complex, high-risk percutaneous coronary intervention and haemodynamic support with intra-aortic balloon versus Impella pump: Real-life single-centre preliminary results.
    Januszek R; Pawlik A; Rzeszutko Ł; Bartuś K; Bartuś S
    Kardiol Pol; 2022; 80(12):1224-1231. PubMed ID: 36047958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Clinical Correlates of Extended Mechanical Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention in Current Clinical Practice: Insights from the cVAD Registry.
    Davila CD; Sharma S; Krishnamoorthy P; Rengifo-Moreno P; Palacios IF; O'Neill W; Kapur NK; Witzke CF
    Cardiovasc Revasc Med; 2020 Mar; 21(3):342-347. PubMed ID: 31227392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
    Doshi R; Patel K; Decter D; Jauhar R; Meraj P
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Alraies MC; Kaki A; Kajy M; Blank N; Hasan R; Htun WW; Glazier JJ; Elder M; O'Neill WW; Grines CL; Schreiber T
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):536-544. PubMed ID: 31631515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Azzalini L; Johal GS; Baber U; Bander J; Moreno PR; Bazi L; Kapur V; Barman N; Kini AS; Sharma SK
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):E26-E33. PubMed ID: 32333721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender difference with the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: From pVAD Working Group.
    Doshi R; Singh A; Jauhar R; Meraj PM
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):369-378. PubMed ID: 29308660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
    Flaherty MP; Pant S; Patel SV; Kilgore T; Dassanayaka S; Loughran JH; Rawasia W; Dawn B; Cheng A; Bartoli CR
    Circ Res; 2017 Feb; 120(4):692-700. PubMed ID: 28073804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Mechanical Circulatory Support During Percutaneous Coronary Intervention in Patients Without Severely Depressed Left Ventricular Function.
    Alaswad K; Basir MB; Khandelwal A; Schreiber T; Lombardi W; O'Neill W
    Am J Cardiol; 2018 Mar; 121(6):703-708. PubMed ID: 29370923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.
    Flaherty MP; Moses JW; Westenfeld R; Palacios I; O'Neill WW; Schreiber TL; Lim MJ; Kaki A; Ghiu I; Mehran R
    Catheter Cardiovasc Interv; 2020 May; 95(6):1111-1121. PubMed ID: 31355987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
    Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
    Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impella Recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention.
    Kovacic JC; Nguyen HT; Karajgikar R; Sharma SK; Kini AS
    Catheter Cardiovasc Interv; 2013 Jul; 82(1):E28-37. PubMed ID: 21234916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of rotational atherectomy in patients with severe left ventricular dysfunction without hemodynamic support.
    Whiteside HL; Ratanapo S; Nagabandi A; Kapoor D
    Cardiovasc Revasc Med; 2018 Sep; 19(6):660-665. PubMed ID: 29525558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention.
    Kar B; Forrester M; Gemmato C; Civitello A; Loyalka P; Myers T; Reynolds D
    J Invasive Cardiol; 2006 Mar; 18(3):93-6. PubMed ID: 16598104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Russo JJ; Prasad M; Doshi D; Karmpaliotis D; Parikh MA; Ali ZA; Popma JJ; Pershad A; Ohman EM; Douglas PS; O'Neill WW; Leon MB; Moses JW; Kirtane AJ
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):764-770. PubMed ID: 31693292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.